Dr. Anna Wolska from the Lupus Foundation of America interviews Dr. Andrea Fava from Johns Hopkins University about Belimumab treatment in lupus nephritis. Dr Fava elucidates on the correlation between the decrease in urinary CD163 levels and the response to Belimumab treatment in Lupus Nephritis trials. The conversation provides important insights into the efficacy of this treatment option and potential biomarker use for personalized and precision medicine in the future.
 
Read the article: <a href='https://gate.sc?url=http%3A%2F%2Fdx.doi.org%2F10.1136%2Flupus-2022-000763&token=e9b060-1-1684936882078'>dx.doi.org/10.1136/lupus-2022-000763</a>

Dr. Anna Wolska from the Lupus Foundation of America interviews Dr. Andrea Fava from Johns Hopkins University about Belimumab treatment in lupus nephritis. Dr Fava elucidates on the correlation between the decrease in urinary CD163 levels and the response to Belimumab treatment in Lupus Nephritis trials. The conversation provides important insights into the efficacy of this treatment option and potential biomarker use for personalized and precision medicine in the future. Read the article: dx.doi.org/10.1136/lupus-2022-000763

Dr. Anna Wolska from the Lupus Foundation of America interviews Dr. Andrea Fava from Johns Hopkins University about Belimumab treatment in lupus nephritis. Dr Fava elucidates on the correlation between the decrease in urinary CD163 levels and the response to Belimumab treatment in Lupus Nephritis trials. The conversation provides important insights into the efficacy of this treatment option and potential biomarker use for personalized and precision medicine in the future.
&nbsp;
Read the article: <a href="https://gate.sc?url=http%3A%2F%2Fdx.doi.org%2F10.1136%2Flupus-2022-000763&amp;token=e9b060-1-1684936882078" rel="noopener noreferrer">dx.doi.org/10.1136/lupus-2022-000763</a>

Biomarker reduction indicates treatment response to Belimumab

The Lupus Science & Medicine® podcast is your premier source for the latest insights and developments in lupus and related diseases. Each episode features in-depth interviews with authors and leading experts, covering the newest advances in lupus research and treatments.

Lupus Science & Medicine® - lupus.bmj.com - is an esteemed international journal from the BMJ Group and the Lupus Foundation of America (LFA). The journal publishes basic, clinical, translational, and epidemiological studies of all aspects of lupus and related diseases.

Subscribe now or listen on your favourite podcast platform to enhance your understanding of lupus.

Podcast hosted by: 
Dr. Anna Wolska, The Lupus Foundation of America, USA

Medicine

Health & Fitness

The Lupus Science & Medicine® podcast is your premier source for the latest insights and developments in lupus and related diseases. Each episode features in-depth interviews with authors and leading experts, covering the newest advances in lupus research and treatments. Lupus Science & Medicine® - lupus.bmj.com - is an esteemed international journal from the BMJ Group and the Lupus Foundation of America (LFA). The journal publishes basic, clinical, translational, and epidemiological studies of all aspects of lupus and related diseases. Subscribe now or listen on your favourite podcast platform to enhance your understanding of lupus. Podcast hosted by: Dr. Anna Wolska, The Lupus Foundation of America, USA

The Lupus Science &amp; Medicine® podcast is your premier source for the latest insights and developments in lupus and related diseases. Each episode features in-depth interviews with authors and leading experts, covering the newest advances in lupus research and treatments.

Lupus Science &amp; Medicine® - lupus.bmj.com - is an esteemed international journal from the BMJ Group and the Lupus Foundation of America (LFA). The journal publishes basic, clinical, translational, and epidemiological studies of all aspects of lupus and related diseases.

Subscribe now or listen on your favourite podcast platform to enhance your understanding of lupus.

Podcast hosted by: 
Dr. Anna Wolska, The Lupus Foundation of America, USA

Share Biomarker reduction indicates treatment response to Belimumab

Sign up to save your podcasts

Biomarker reduction indicates treatment response to Belimumab

Biomarker reduction indicates treatment response to Belimumab

More shows like Lupus Science and Medicine Podcast

TED Talks Daily

Medicine and Science from The BMJ

DTB Podcast

BJSM Podcast

Gut Podcast

Sharp Scratch

ADC Podcast

Thorax Podcast

STI Podcast

JNNP Podcast

Heart Podcast

JNIS Podcast

EBN Podcast

Practical Neurology Podcast

FG Podcast

Medical Humanities Podcast

JAMA Clinical Reviews

Mayo Clinic Talks

The Curbsiders Internal Medicine Podcast

RMD Open Podcast

JAMA Medical News

BMJ Best Practice Podcast

Core IM | Internal Medicine Podcast

Dr. Berg’s Healthy Keto and Intermittent Fasting Podcast

IJGC Podcast

Harrison's PodClass: Internal Medicine Cases and Board Prep

Chronically Planned: Faith, Planning and Healing With Chronic Illness

Lupus: The Expert Series

The Curious Clinicians

Becoming Immune Confident

The Lupus Academy

The Lupus Forum

BMJ Future Health Podcast

Lupus